Back to Search
MARY LACY, M.D.
M.D.
Hospitalist Physician
NPI: 1598064040IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
60391139(WA)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
MD2014-0481(NM)
Education
UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE
Class of 2011
Research & Publications (20)
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
PMID 19648970·Bone Marrow Transplant·2010
3-trial
Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
PMID 19211640·Haematologica·2009
8-other
Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT.
PMID 18850016·Bone Marrow Transplant·2009
5-case
Nosocomial transmission of invasive group a streptococcus from patient to health care worker.
PMID 19580415·Clin Infect Dis·2009
5-case
Neurocognitive outcome after endoscopic third ventriculocisterostomy in patients with obstructive hydrocephalus.
PMID 19402925·J Int Neuropsychol Soc·2009
8-other
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.
PMID 18997825·Bone Marrow Transplant·2009
4-observational
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.
PMID 19181644·Mayo Clin Proc·2009
3-trial
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.
PMID 19324902·Blood·2009
8-other
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
PMID 19403931·Nephrol Dial Transplant·2009
8-other
Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins.
PMID 19427507·Mutat Res·2009
7-preclinical
Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
PMID 19330657·Leuk Lymphoma·2009
8-other
Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group.
PMID 19243818·Leuk Res·2009
3-trial
Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
PMID 18622421·Bone Marrow Transplant·2008
8-other
Impact of early relapse after auto-SCT for multiple myeloma.
PMID 18587435·Bone Marrow Transplant·2008
4-observational
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis.
PMID 18641023·Haematologica·2008
8-other
Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma.
PMID 18474873·J Clin Oncol·2008
3-trial
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
PMID 18429054·Am J Hematol·2008
8-other
Impact of additional cytoreduction following autologous SCT in multiple myeloma.
PMID 18560409·Bone Marrow Transplant·2008
8-other
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
PMID 18656793·J Heart Lung Transplant·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- EVERGREEN HOSPITAL, 12040 NE 128TH ST
KIRKLAND, WA 98034 - Phone
- (859) 583-6273
Quick Facts
- NPI
- 1598064040
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile